Safety of Systemic Agents for the Treatment of Pediatric Psoriasis

IMPORTANCE: Use of systemic therapies for moderate to severe psoriasis in children is increasing, but comparative data on their use and toxicities are limited. OBJECTIVE: To assess patterns of use and relative risks of systemic agents for moderate to severe psoriasis in children. DESIGN, SETTING, AN...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:JAMA Dermatol
Glavni autori: Bronckers, Inge M. G. J., Seyger, Marieke M. B., West, Dennis P., Lara-Corrales, Irene, Tollefson, Megha, Tom, Wynnis L., Hogeling, Marcia, Belazarian, Leah, Zachariae, Claus, Mahé, Emmanuel, Siegfried, Elaine, Philipp, Sandra, Szalai, Zsuzsanna, Vleugels, Ruth Ann, Holland, Kristen, Murphy, Ruth, Baselga, Eulalia, Cordoro, Kelly, Lambert, Jo, Alexopoulos, Alex, Mrowietz, Ulrich, Kievit, Wietske, Paller, Amy S.
Format: Artigo
Jezik:Inglês
Izdano: American Medical Association 2017
Teme:
Original Investigation
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710436/
https://ncbi.nlm.nih.gov/pubmed/28903160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2017.3029
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items